| Description | GDE1 Human Pre-designed siRNA Set A contains three designed siRNAs for GDE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GDE1 siRNA-1: 5 nmol (HPLC) GDE1 siRNA-2: 5 nmol (HPLC) GDE1 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 GDE1 Human Pre-designed siRNA Set A contains three designed siRNAs for GDE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GDE1 siRNA-1: 5 nmol (HPLC) GDE1 siRNA-2: 5 nmol (HPLC) GDE1 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA has encephalitogenic activity and induces T cell proliferative. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA induces Th1 cytokine response as well as relatively high levels of IgG antibodies. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA produces a relapsing-remitting neurological disease with extensive plaque-like demyelination... Read More | Inquire | Purity>97% by SDS-PAGE and HPLC analyses.Additional sequence informationN-terminal Glycine.FunctionChemotactic for monocytes and T-lymphocytes. Binds to CXCR3.Post-translationalCXCL10(1-73) is produced by proteolytic cleavage after secretion from keratinocytes |